Tenax Therapeutics, Inc. announced it raised $5.17 Million in an initial filing from an offering of $5.17 Million

Jul 22, 2020•almost 5 years ago

Amount Raised

$5.17 Million

Chapell HillHealthcare

Company Information

Company

Tenax Therapeutics

Location

101 GLEN LENNOX DRIVE

Chapell Hill, North Carolina, United States

About

Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company focused on developing and commercializing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with a current focus on pulmonary hypertension.

FundzWatch™ Score

Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Tenax Therapeutics, Inc. announced it raised $5.17 Million in an initial filing from an offering of $5.17 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

FundzWatch™ Score

Buyer Intent Analysis

Related People

Company Information